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Objective. To examine the value of one-step uterine artery Doppler at 20 weeks of gestation in the prediction pre-eclampsia (PE)
and/or intrauterine growth restriction (IUGR). Methods. A prospective multicentre study that included all women with singleton
pregnancies at 19–22 weeks of gestation (w). The mean pulsatility index (mPI) of both uterine arteries was calculated. Receiver-
operating characteristics curves (ROC) were drawn to compare uterine artery Doppler and maternal risk factors for the prediction
of early-onset PE and/or IUGR (before 32 w) and late-onset PE and/or IUGR. Results. 6,586 women were included in the study.
Complete outcome data was recorded for 6,035 of these women (91.6%). PE developed in 75 (1.2%) and IUGR in 69 (1.1%)
cases. Uterine Doppler mPI was 0.99 and the 90th centile was 1.40. For 10% false-positive rate, uterine Doppler mPI identified
70.6% of pregnancies that subsequently developed early-onset PE and 73.3% of pregnancies that developed early-onset IUGR.
The test had a lower detection rate for the late-onset forms of the disease (23.5% for PE and 30% for IUGR). Maternal history has
a low sensitivity in the detection of early-onset cases, although it is better at detecting late-onset PE. Conclusion. Uterine artery
Doppler and maternal risk factors seem to select two diﬀerent populations - early and late-onset PE which might suggest a diﬀerent
pathogenesis.
Copyright © 2009 Elisa Llurba et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Pre-eclampsia (PE) and intrauterine growth restriction
(IUGR), which aﬀect 4–10% of all pregnancies, are the
leading cause of premature iatrogenic deliveries and maternal
morbidity in developed countries [1]. One of the major goals
of fetal-maternal medicine is to detect those cases at risk early
enough in pregnancy to be able to tailor interventions to
improve maternal and fetal outcomes.
Both PE and IUGR are associated with pathogenic evi-
dence of placental underperfusion and ischemia [2, 3]. Blood
flow through the uteroplacental circulation can be studied
noninvasively using Doppler ultrasound. In pregnancies with
PE or IUGR, impedance of flow in the uterine arteries
increases before the clinical signs of the disease are seen [4, 5].
These findings have been supported by histologic studies that
show that Doppler resistance index is inversely related to the
percentage of vessels with trophoblastic invasion [6].
Implementation of uterine Doppler as a screening test
has been limited due to the high variability in the sensitivity
of PE, ranging from 30 to 80, together with a high false-
positive rate [7]. The disparity of results when assessing
eﬃcacy of this screening test is due to diﬀerences in
Doppler technique, the definition of abnormal flow velocity
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wave form, the population selected, or gestational age at
the moment of screening [8]. In fact, the importance of
distinguishing PE from transient hypertension in pregnancy
or IUGR from constitutional small babies has only recently
been considered [9]. Some studies used a two-stage program
assessment [10–13], whereas nowadays one step evaluation
at the moment of the anomaly scan (around 20 w in the
majority of European countries) would be enough in clinical
practice [14]. There are only two studies that evaluate uterine
artery Doppler screening at 20 w of gestation [15, 16];
however, in both cases the number of patients was too small
to draw meaningful conclusions.
Therefore, the aim of our study was to examine the value
of one-step uterine artery Doppler and maternal risk factors
at 20 weeks of gestation in the prediction of early-onset and
late-onset pre-eclampsia (PE) and/or intrauterine growth
restriction (IUGR) in an unselected population. Moreover,
we wanted to ascertain whether uterine artery Doppler is
more eﬀective in a high risk population.
2. Material andMethods
2.1. Study Population. This was a multicentric screening
study involving Doppler ultrasound examination of the
uterine arteries at 19–22 weeks of gestation in women with
singleton pregnancies attending a routine second trimester
anomaly scan. The study period was from June 2002 to May
2006.
The study was approved by the ethical committees of
each hospital that took part. The participating hospitals
were Hospital Son Llatzer de Mallorca, Hospital de Terrasa,
Hospital de Granollers, and Hospital Vall d’Hebron de
Barcelona (Spain). In these centers, all women who attended
routine care were oﬀered a transabdominal ultrasound
examination at 19–22 weeks of gestation for measurement
of fetal growth and examination for fetal abnormalities. All
women with no major fetal abnormality were oﬀered the
option of uterine artery Doppler evaluation. Written consent
was obtained in all cases. A first trimester scan was preformed
in all patients, and CRL measurement was used to date the
pregnancy. All sonographers were obstetricians specialized
in fetal ultrasound. Quality control of screening, handling
of data, and verification of adherence to protocols at the
diﬀerent centers were performed by the trial coordinators.
Managing clinicians were blinded to the uterine Doppler
measurements. As a result, there was no special follow-up for
pregnant women with increased resistance in uterine arteries.
2.2. Uterine Artery Doppler Evaluation. Uterine artery
Doppler velocimetry was evaluated at 19–22 weeks of
gestation by abdominal ultrasound using 6–4 MHz probes
Siemens Sonoline Antares (Siemens Medical, Erlangen, Ger-
many); Acuson SP-10 (Acuson, Mountain View, Ca, USA);
Aloka 5000 and Aloka 1700 (aloka, Tokyo, Japan); Toshiba
SSH-140 (Toshiba, Tokyo, Japan).
Flow velocity waveforms of the right and left uterine
arteries were imaged with the patient semirecumbent, and
the uterine artery was identified on a longitudinal scan,
lateral to the uterus. In that position the scan showed the
bifurcation of the common iliac artery. Recording was made
at the point where the uterine artery and the external iliac
artery appeared to have crossed each other, as detected
by color flow Doppler. Pulsed wave Doppler was then
used to obtain three consecutive waveforms. Following this,
pulsatility index (PI) was measured, and the presence or
absence of an early diastolic notch was noted. The process
was then repeated for the contralateral uterine artery, and the
mean PI (mPI) of the two vessels was calculated.
Maternal history risk factors were obtained prospectively.
Patients were asked to complete a questionnaire on maternal
age, race, height, weight, smoking status, obstetric history
(previous PE, IUGR, abruption, or stillbirth), and medical
history including chronic hypertension or diabetes. Maternal
history risk factors were obtained from a questionnaire,
although data were confirmed, when possible, by the exam-
ination of clinical history. Demographic characteristics and
Doppler findings were recorded in a computer database at
the time of Doppler studies in every participating center.
Data on pregnancy outcomes were obtained from examina-
tion of each patient’s clinical history and labor ward records.
For the purpose of this study both IUGR and PE were
classified as early onset (gestational age under 32 weeks at
delivery) or late onset (32 weeks or over). The classification
of pre-eclampsia at or near to term has clinical importance
since early-onset PE is commonly associated with IUGR,
abnormal uterine and umbilical artery Doppler evaluation
and adverse maternal and neonatal outcomes. In contrast to
this, late-onset PE is mainly associated with a mild maternal
disease and low rate of fetal involvement, and therefore
perinatal outcome is usually favorable. Patients with severe
early-onset PE have diﬀerent risk factors compared to
late-onset PE [17, 18]. Criteria for the definition of PE
were those of the International Society for the Study of
Hypertension in Pregnancy [19]. PE was diagnosed if a
previously normotensive woman had her diastolic blood
pressure above 90 mmHg measured twice (4 hours apart)
and also had proteinuria of more than 300 mg in a 24-hour
urine specimen or 2+ protein dipsticks twice (4 hours apart)
after the 20th week of gestation. IUGR was diagnosed if
the estimated fetal weight was below the 10th percentile for
gestational age in our population, together with a Doppler
PI in the umbilical artery above the 95th percentile, or
if the estimated fetal weight was below the 3rd percentile
irrespective of the umbilical artery Doppler [20].
2.3. Statistical Analysis. Mean PI was not normally dis-
tributed and therefore expressed as median ± interquartile
range (IQR). Fisher’s exact test was used to analyze maternal
history variables, and independent t-test—Mann-Whitney
U test—was used for continuous variables analysis where
appropiate.
The sensitivity (S), specificity (E), positive predictive
value (PPV), negative predictive value (NPV), and likelihood
ratio (LR) for a cut-oﬀ mean PI of 1.66 (95th centile) and
for a mean PI of 1.40 (90th centile) and presence of bilateral
notches in the prediction of preeclampsia and/or IUGR were
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Table 1: ORs for risk factors for the development of PE in the maternal history.
Characteristic N (%) OR CI 95% P
Age >34 17 (1.5) 1.33 (0.77–2.30) .322
Nulliparus 46 (1.9) 2.52 (1.53–4.14) <.001
Race other than white 13 (1.6) 1.32 (0.72–2.41) .386
BMI ≥30 17 (2.4) 2.39 (1.37–4.15) .002
Smoker Yes 7 (0.5) 0.33 (0.15–0.72) .001
Chronic hypertension Yes 10 (10.9) 9.22 (4.60–18.5) <.001
Diabetes I/II Yes 4 (4.5) 4.5 (1.38–10.8) <.031
Previous PE Yes 9 (11.1) 11.22 (5.38–23.4) <.001
Previous IUGR Yes 3 (4.5) 3.91 (1.2–12.7) .024
Previous abruption Yes 1 (4.2) 3.5 (1.4 + 10.9) .306
Previous stillbirth Yes 4 (3.6) 3.06 (1.1–8.55) .032
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Figure 1: Frequency distribution of mean Pulsatility Index (mPI)
uterine artery Doppler in the study population.
calculated. Diﬀerences were considered significant when P <
.05.
Logistic regression was used to obtain the odds ratio
(OR) and 95% CI for PE in relation to maternal history
variables. A multivariate analysis to draw the receiver-
operating characteristics curves (ROC) was performed using
maternal history variables found to be independent in a
univariate analysis.
The sensitivity and specificity for diﬀerent cut-oﬀs in
marker levels were calculated, and ROC were drawn to
compare the performances of uterine Doppler and maternal
risk factor tests. ROC analysis was also used to compare
uterine artery Doppler in low- and high-risk populations.
Data was analyzed using SPSS 13.0 (SPSS, Chicago, Ill,
USA) and STATA/SE 8.2 statistical packages.
3. Results
Doppler examination of the uterine arteries was attempted
in 6586 consecutive singleton pregnancies. Satisfactory wave-
forms were obtained from both vessels in 6535 cases (99%).
Complete outcome data was recorded in 6035 cases (91.6%),
which formed the population for our study. No diﬀerences
were found in the demographic and screening characteristics
of the 6035 pregnancies with follow-up and those lost
for follow-up, except for their smoking status, that was
significantly higher in the group with complete follow-up
(data not shown). In Table 1 we presented the maternal risk
factors for the development of PE. There was an increased
risk for PE in nulliparus, in noncaucasian women, in women
with a body mass index (BMI) >30 and in those with a
history of hypertension, previous PE, stillbirth, or abruption.
The risk of PE decreased in cigarette smokers.
Uterine artery mPI was not normally distributed but was
found to be skewed to the right with a mean value of 0.99 and
the 95th percentile of 1.66 (Figure 1). In the group of women
who subsequently developed PE/IUGR, mPI was higher than
in those who did not develop any complication (median 1.36
(0.70) versus 0.93 (0.30), P < .001). The highest values of
mPI were among patients that developed early-onset disease
(median 1.68 (0.40) versus 1.31 (0.43), P < .01).
Overall, PE occurred in 75 cases (1.2%), early-onset PE in
20 cases (0.3%), IUGR in 69 cases (1.1%); early-onset IUGR
in 33 cases (0.5%) and early-onset PE with IUGR in 38 cases
(0.6%). Screening characteristics for early-onset PE/IUGR
between uterine artery mPI > 1.66 (95th percentile) and/or
bilateral notches are set out in Table 2. Uterine artery mPI >
1.40 (90th percentile) was able to detect 73.7% of early-onset
PE/IUGR with the same false-positive rate (10%) as mPI >
95th plus bilateral notches, as shown in Table 3.
In order to perform a combined assessment, uterine
artery mPI was compared with the maternal history variables
in women who subsequently developed PE and those who
did not. Moreover, we were able to diﬀerentiate early- and
late-onset PE by drawing ROC curves to compare the two
methods of screening for early-onset PE (Figure 2) and late-
onset PE (Figure 3). By comparing the areas under the
curves, it was shown that uterine Doppler mPI (AUC = 0.90,
95% CI (0.85–0.96) P < .001) seemed to perform better than
maternal history alone (AUC = 0.75, 95% CI (0.63–0.87)
P = .001) in detection of early-onset PE, although there was
no statistical diﬀerence when we compared both AUCs (P =
.076). The performance of uterine Doppler mPI assessment
of risk (AUC = 0.70, 95% CI (0.61–0.78) P < .001) was
not statistically diﬀerent from maternal history (AUC = 0.77,
95% CI (0.69–0.84, P < .001) for late-onset PE (P = .254).
The combination of the two methods did little to increase
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Table 2: Screening characteristics for mean PI > 1.66 and/or bilateral Notches at 20 w (screen positive rate: 9.2%).
S (%) E (%) PPV (%) NPV (%) LR+ LR−
PE 48.0 91.3 6.5 99.3 5.5 0.18
PE < 32 w 75.0 91.0 2.7 99.9 8.3 0.12
PE ≥ 32 w 38.9 91.0 3.8 99.4 4.3 0.23
IUGR 52.2 91.3 6.5 99.4 6.0 0.17
IUGR < 32 w 72.7 91.1 4.3 99.8 8.2 0.12
IUGR ≥ 32 w 33.3 90.9 2.2 99.6 3.7 0.27
PE and/or IUGR < 32 73.7 91.2 5.0 99.8 8.4 0.12
PE and IUGR 65.2 91.0 2.7 99.9 7.2 0.14
PE and IUGR < 32 s 73.3 90.9 2.0 99.9 8.1 0.12
PE and IUGR ≥ 32 s 50.0 90.8 0.7 99.9 5.5 0.18
Table 3: Screening characteristics for mean PI > 1.40 irrespective of bilateral Notches at 20 w (screen positive rate: 10%).
S (%) E (%) PPV (%) NPV (%) LR+ LR−
PE 46.0 90.0 5.2 99.3 4.7 0.21
PE < 32 w 70.6 90.0 2.0 99.9 7.4 0.14
PE ≥ 32 w 39.2 90.0 3.3 99.4 3.9 0.20
IUGR 57.1 90.3 5.9 99.5 6.0 0.17
IUGR < 32 w 73.3 90.1 3.6 99.9 7.4 0.13
IUGR ≥ 32 w 42.4 90.0 3.3 99.4 3.9 0.25
PE and/or IUGR < 32 71.4 90.0 4.1 99.8 7.3 0.14
PE and IUGR 68.4 90.0 2.1 99.9 6.8 0.15
PE and IUGR < 32 s 75.0 89.9 1.5 99.9 7.5 0.13
PE and IUGR ≥ 32 s 57.1 89.9 0.7 99.9 5.6 0.18
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Figure 2: Receiver-operating characteristic curves showing the
sensitivities for given screen-positive rates of uterine Doppler mean
PI assessment (mPI), maternal history characteristics (History) and
the combination of both methods (Combined) in the detection of
early-onset PE.
the sensitivity of either early- or late-onset PE. Uterine artery
Doppler performance for risk assessment of early-onset PE in
the low-risk population (AUC = 0.91, 95% CI (0.850–0.972)
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Figure 3: Receiver-operating characteristic curves showing the
higher sensitivities for given screen-positive rates of uterine Doppler
mean PI assessment (mPI), maternal history characteristics (His-
tory) and the combination of both methods (Combined) in the
detection of late-onset PE.
P < .002) and in the high-risk population (AUC = 0.87, 95%
CI (0.718–1.00) P = .062) showed no diﬀerences (P = .53)
in detection of early-onset PE.
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4. Discussion
The results of this study demonstrate that uterine artery
Doppler is an eﬀective screening program for the predic-
tion of PE and IUGR in an unselected population with
classically low incidence of PE. Our findings have shown
that measurement of the uterine artery mPI at 20 weeks
gestation can identify 70.6% of pregnancies that will sub-
sequently develop early-onset PE and 73.3% of pregnancies
that develop early-onset IUGR, with a 10% false-positive
rate.
In our screening program, the gestational age was moved
to 19–22 weeks, which is when the routine abnormality
scan is normally performed in most countries. Although a
two-stage screening program has been recommended due
to a higher false-positive rate around 20 weeks of gestation
[21], we have found that, for the same false-positive rate, a
one-stage screening test at 20 weeks gestation has a similar
detection rate for PE or IUGR to studies performed at 22–24
weeks gestation [9].
We have also determined that with the same false-positive
rate (10%), uterine Doppler mPI gave similar results to
bilateral notches and mPI, so the addition of bilateral notches
did nothing to improve screening characteristics. Moreover,
the use of the PI has removed any subjectivity associated with
the definition and interpretation of the presence of notches in
the waveform [7].
While there is no eﬀective therapeutic measure for the
prevention of PE and/or IUGR, NICE guideline recom-
mendations point out that a woman’s degree of risk for
PE should be evaluated so that an appropriate plan for
subsequent scheduling of antenatal appointments [22] and
ultrasound growth scans can be formulated. There are no
direct iatrogenic procedures that could aﬀect mother or
fetus after being classified as high risk for these conditions,
so it would be reasonable to maximize the detection rate
even at the cost of a slightly higher screen-positive rate.
Nonetheless, such a classification may cause anxiety even
though increased surveillance can improve maternal and
neonatal outcome. We have found that uterine Doppler
mPI had a good sensitivity even in the low-risk population,
precisely, the group of patients that benefit most from a
program of specific follow-up.
We have considered early-onset PE and IUGR as diﬀerent
outcomes from those conditions that were diagnosed near to
term. Previous studies have established that uterine Doppler
is much better at identifying the more severe early-onset
cases [14, 23–26]. It has also been demonstrated that uterine
Doppler screening is better in predicting severe early-onset
disease or PE associated with IUGR, with sensitivities of 80 to
90% [9]. To add to this, we have shown that uterine Doppler
mPI performed better than maternal history in the detection
of early-onset PE, whereas maternal history alone is similar
to uterine Doppler mPI in the detection of late-onset PE. The
combination of both methods did not significantly improve
the sensitivity in early- or late-onset disease. We are aware
of the limitations of maternal historical data as this piece
of information relies on medical records and maternal self-
reporting.
The classification of PE at or near term has clinical
importance since early-onset PE is commonly associated
with IUGR, abnormal uterine Doppler, and adverse maternal
and neonatal outcomes [17, 27–29]. In contrast, late-onset
PE is mainly associated with a milder form of maternal illness
and low rate of fetal involvement, so perinatal outcome is
usually favorable [17, 28]. Patients with severe early-onset
PE have diﬀerent risk factors compared to late-onset PE
[29, 30]. Moreover, we have recently demonstrated that
patients with early-onset PE (<32 weeks) had abnormal
uterine Doppler mPI, whereas, in late-onset PE (>32 weeks),
only a proportion of these cases presented abnormal uterine
Doppler assessment, suggesting that there is a subgroup of
late-onset cases with minimal placental involvement [28].
In conclusion, our results now show that a single 20
weeks uterine Doppler assessment was feasible and useful
and is able to detect pregnant women with a high risk
for early-onset adverse outcomes that relate to impaired
trophoblast invasion in the low- and high-risk populations.
In women with late-onset PE, maternal history and uterine
Doppler are less eﬀective in identifying those women at
risk, signifying that late-onset PE could result from het-
erogeneous causes in the context of absent or minimal
placental impairment. These findings require a shift away
from the general concept of PE as a single entity toward
defining diﬀerent types of PE classified according to cause.
The application of this screening test in routine clinical
practice needs future studies to demonstrate that uterine
artery Doppler is useful to identify the population with a
higher risk to pregnancy complications for whom intensive
surveillance could improve maternal and fetal health.
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